11.11.05
Patent No. US 6,455,054 B1: Societe L’Oréal researchers in France patented a regimen for treating sensitive skin, skin discomfort, tautness, itchiness or swelling, red blotches or burning or warming of the skin using at least one 2-amino 4-alkylaminopyrimidine 3-oxide compound.